Lifecore Biomedical Inc
NASDAQ:LFCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indo Amines Ltd
NSE:INDOAMIN
|
IN |
|
Gibus SpA
MIL:GBUS
|
IT |
|
S
|
Skarbiec Holding SA
WSE:SKH
|
PL |
Lifecore Biomedical Inc
Long-Term Debt
Lifecore Biomedical Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Long-Term Debt
$141.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
|
|
Hershey Co
NYSE:HSY
|
Long-Term Debt
$4.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
12%
|
|
|
Tyson Foods Inc
NYSE:TSN
|
Long-Term Debt
$7.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
2%
|
|
|
Kellogg Co
NYSE:K
|
Long-Term Debt
$4.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-3%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Long-Term Debt
$19.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Long-Term Debt
$17.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Long-Term Debt?
Long-Term Debt
141.3m
USD
Based on the financial report for Dec 31, 2025, Lifecore Biomedical Inc's Long-Term Debt amounts to 141.3m USD.
What is Lifecore Biomedical Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
15%
Over the last year, the Long-Term Debt growth was 19%.
